Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision label in the page footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no substantive changes to the study page content are evident.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 added and v3.4.0 removed on the site; no impact on study details or documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a Show glossary option and updated QC-related metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older QC label, No FEAR Act data, and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedIntroduced a centralized Locations section listing participating sites by region (including US states and Flemish Brabant) and removed the separate per-location 'Locations' subpages in favor of the consolidated section; Revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.